Clinical Trial Update: Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating paclitaxel plus capecitabine with capecitabine maintenance in metastatic adenocarcinoma of the stomach or esophagogastric junction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Peking University | Conditions: Advanced Gastric Cancer | Phase 3 | Status: UNKNOWN